Stephanie L. Lee, MD, PhD

Professor, Medicine

Stephanie Lee
sltal@bu.edu
75 E. Newton St
View full profile at BUMC

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Websites

Education

  • University of California, San Diego, MD
  • University of California, San Diego, PhD
  • University of California, Santa Barbara, BA

Publications

  • Published on 2/2/2024

    Goundan PN, Lye T, Markel A, Mamou J, Lee SL. Improved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound. Front Endocrinol (Lausanne). 2024; 15:1326188. PMID: 38370358.

    Read at: PubMed
  • Published on 9/27/2023

    Kang H, Drake FT, McAneny D, Lee SL. False-positive Imaging for Papillary Thyroid Cancer Caused by Intraosseous Hemangiomas. JCEM Case Rep. 2023 Sep; 1(5):luad102. PMID: 37908210.

    Read at: PubMed
  • Published on 8/1/2023

    Sipos JA, Aloi J, Gianoukakis A, Lee SL, Klopper JP, Kung JT, Lupo MA, Morgenstern D, Prat-Knoll C, Schuetzenmeister A, Goldner WS. Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer. J Endocr Soc. 2023 Aug 01; 7(9):bvad102. PMID: 37564885.

    Read at: PubMed
  • Published on 10/31/2022

    Sarkar R, Lee SL, Kumar V, Thakur S. Editorial: Thyroid cancer: New perspectives in diagnosis and therapy. Front Pharmacol. 2022; 13:1057731. PMID: 36386151.

    Read at: PubMed
  • Published on 2/14/2022

    Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022; 13:20420188211058583. PMID: 35186251.

    Read at: PubMed
  • Published on 5/19/2021

    Goundan PN, Mamou J, Rohrbach D, Smith J, Patel H, Wallace KD, Feleppa EJ, Lee SL. A Preliminary Study of Quantitative Ultrasound for Cancer-Risk Assessment of Thyroid Nodules. Front Endocrinol (Lausanne). 2021; 12:627698. PMID: 34093429.

    Read at: PubMed
  • Published on 12/15/2020

    Haddady S, Pinjic E, Lee SL. Prognostic Value of Serum Thyroglobulin Measured at 48 Hours Versus 72 Hours after Second Dose of Recombinant Human Thyrotropin in Surveillance of Well-Differentiated Thyroid Cancer. Endocr Pract. 2021 Mar; 27(3):216-222. PMID: 33779554.

    Read at: PubMed
  • Published on 12/3/2020

    Vodopivec DM, Thomas DD, Palermo NE, Steenkamp DW, Lee SL. Looking for the Outsider. N Engl J Med. 2020 12 03; 383(23):2275-2281. PMID: 33264549.

    Read at: PubMed
  • Published on 11/1/2020

    Guan H, Toraldo G, Godley FA, Rao SR, Cerda S, McAneny D, Doherty G, Lee SL. The real-world performance of ThyroSeqV.2 to diagnose thyroid "neoplasm requiring surgery". Am J Cancer Res. 2020; 10(11):3838-3851. PMID: 33294271.

    Read at: PubMed
  • Published on 10/1/2020

    Goundan PN, Lee SL. Thyroid effects of amiodarone: clinical update. Curr Opin Endocrinol Diabetes Obes. 2020 10; 27(5):329-334. PMID: 32773570.

    Read at: PubMed

View 65 more publications: View full profile at BUMC

View all profiles